1. Pike, Malcolm C. 美国 Memorial Sloan Kettering Cancer Center 1994美国医学院院士 The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovari..
2. Pike, Malcolm C. 美国 Memorial Sloan Kettering Cancer Center 1994美国医学院院士 The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovari..
3. Bert W. O'Malley 美国 Baylor College of Medicine 1993美国医学院院士;1992美国科学院院士 Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
4. 张兴栋 中国 四川大学 教授/研究员/特聘研究员 2014美国工程院院士;中国工程院院士 Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cell..
5. 刘昌胜 中国 华东理工大学 中国科学院院士 Harnessing 4D Printing Bioscaffolds for Advanced Orthopedics
6. 李兰娟 中国 浙江大学 中国工程院院士 The functional roles of the circRNA/Wnt axis in cancer
7. 赫捷 中国 中国医学科学院 中国科学院院士 ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC
8. 张心湜 中国 台湾阳明大学 中国工程院院士 MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer met..
9. 赫捷 中国 中国医学科学院 中国科学院院士 Society for Translational Medicine expert consensus on training and certification standards for surg..
10. 贺林 中国 上海交通大学 讲席教授 中国科学院院士 Conversion of female germline stem cells from neonatal and prepubertal mice into pluripotent stem ce..
11. Darzi, Ara , FMedSci 英国 Imperial College London 2013美国医学院院士 Safety of training and assessment in operating theatres - a systematic review and meta-analysis
12. Lisa,Mirabello 美国 National Cancer Institute Analysis of the progression of cervical cancer in a low-and-middle-income country: From pre-malignan..
13. Michael,Dean 美国 Center Cancer Research Analysis of the progression of cervical cancer in a low-and-middle-income country: From pre-malignan..
14. 吴敏 中国 四川大学 TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology
15. Egbert F,Smit 荷兰 Netherlands Cancer Institute Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Res..
16. Gelderblom, Hans 荷兰 Leiden University Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Res..
17. Verheul, Henk M. W. 荷兰 Radboud University Nijmegen Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Res..
18. Emile E,Voest 荷兰 Netherlands Cancer Institute Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Res..
19. Chiu, Philip Wai Yan 中国 香港中文大学 Design, Analysis, and Preliminary Validation of Magnetic Anchored and Cable Driven Endoscope for Min..
20. 宋勇 中国 东部战区总医院 教授、主任医师 Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Mul..